Radiomic Deformation and Textural Heterogeneity (R-DepTH) Descriptor to Characterize Tumor Field Effect: Application to Survival Prediction in Glioblastoma.

Publication Year: 2022

DOI:
10.1109/TMI.2022.3148780

PMCID:
PMC9575333

PMID:
35108202

Journal Information

Full Title: IEEE Trans Med Imaging

Abbreviation: IEEE Trans Med Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"This work was supported in part by the NIH under Award 1U24CA199374-01, Award R01CA202752-01A1, Award R01CA208236-01A1, Award R01CA216579-01A1, Award R01CA220581-01A1, Award 1U01CA239055-01, Award 1U01CA248226-01, Award 1U54CA254566-01, and Award 1P20CA233216-01; in part by the National Institute for Biomedical Imaging and Bioengineering under Grant 1R43EB028736-01; in part by the National Center for Research Resources under Award 1C06RR12463-01; in part by the National Heart, Lung, and Blood Institute under Grant 1R01HL15127701A1; in part by the Veterans Administration (VA) Merit Review Award from the U.S. Department of Veterans Affairs under Grant IBX004121A; in part by the Biomedical Laboratory Research and Development Service; in part by the DOD Prostate Cancer Idea Development Award under Grant W81XWH-15-1-0558; in part by the DOD Lung Cancer Investigator-Initiated Translational Research Award under Grant W81XWH-18-1-0440; in part by the DOD Peer Reviewed Cancer Research Program (PRCRP) under Grant W81XWH-16-1-0329; in part by the National Institute of Diabetes and Digestive and Kidney Diseases under Grant 1K25 DK115904-01A1; in part by the Ohio Third Frontier Technology Validation Fund; in part by the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering and the Clinical and Translational Science Award Program (CTSA) at Case Western Reserve University; in part by the Department of Defense PRCRP Career Development Award; in part by the Dana Foundation David Mahoney Neuroimaging Program; in part by the V Translational Cancer Research Foundation; in part by the America Brain Tumor Association under Grant DG1600004; and in part by the NIH/National Cancer Institute (NCI) under Grant R01CA218144."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025